IMVT compared with ROIV: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IMVT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±9.0%▲+1.17%×0.13

May 20 '26±15.6%▲+35.26%×2.26

Feb 6 '26±13.5%▲+12.43%×0.92

Nov 10 '25±16.2%▲+0.09%×0.01

ROIV

0 of 1at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±8.4%▲+1.50%×0.18

May 20 '26—▲+14.89%—

= impliedIMVT realized, solidROIV realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

Apr 2 '26

—

▲+1.76%

—

Feb 6 '26—▲+22.14%—

IMVTImmunovant, Inc.

30.51▲+7.47%· post 30.00

Mkt cap$5.9BRevenue—Revenue—

ROIVRoivant Sciences Ltd.

38.90▲+6.23%· post 38.88

ClosedNov 6 '26

Mkt cap$26.5BRevenue$1MQ1 FY26Revenue$8MFY25

Compare

ClosedNov 6 '26

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

30.51▲+7.47%post 30.00

Price

38.90▲+6.23%post 38.88

$5.9B

Mkt cap

$26.5B

—

Revenue

$1MQ1 FY26

—

Revenue

$8MFY25

IMVT30.51▲+7.47%vsROIV38.90▲+6.23%ClosedNov 6 '26